Immunosuppressant therapeutic drug monitoring and trough level stabilisation after paediatric liver or kidney transplantation

Posfay Barbe, Klara; Baudet, Henri; Mclin, Valérie Anne; Parvex, Paloma Maria; Chehade, Hassib; Combescure, Christophe; Bonnabry, Pascal; Fonzo-Christe, Caroline Cécile

doi:10.4414/smw.2019.20156

Scientific article

English

Immunosuppressant therapeutic drug monitoring and trough level stabilisation after paediatric liver or kidney transplantation

ContributorsPosfay Barbe, Klara; Baudet, Henri; Mclin, Valérie Anne; Parvex, Paloma Maria; Chehade, Hassib; Combescure, Christophe

; Bonnabry, Pascal; Fonzo-Christe, Caroline Cécile

Published inSwiss Medical Weekly, vol. 149, w20156

Publication date2019

Abstract

Immunosuppressive therapy must be guided by therapeutic drug monitoring (TDM) in paediatric liver (LT) and kidney transplantation (KT) patients to prevent under- and overdosing, which have clinical consequences.

Keywords

Cyclosporine/therapeutic use
Drug Monitoring
Female
Humans
Immunosuppressive Agents/therapeutic use
Infant
Kidney Transplantation
Liver Transplantation
Living Donors
Male
Pediatrics
Retrospective Studies
Tacrolimus/therapeutic use

Affiliation entities

Research groups

Citation (ISO format)

POSFAY BARBE, Klara et al. Immunosuppressant therapeutic drug monitoring and trough level stabilisation after paediatric liver or kidney transplantation. In: Swiss Medical Weekly, 2019, vol. 149, p. w20156. doi: 10.4414/smw.2019.20156

Article (Published version)

CC BY-NC-ND

Identifiers

PID : unige:145928
DOI : 10.4414/smw.2019.20156
PMID : 31800965

Journal ISSN1424-7860

231views

94downloads

Creation21/10/2020 17:26:00

First validation21/10/2020 17:26:00

Update time15/03/2023 23:40:26

Status update15/03/2023 23:40:25

Last indexation31/10/2024 20:43:52

Archive ouverte UNIGE

Immunosuppressant therapeutic drug monitoring and trough level stabilisation after paediatric liver or kidney transplantation

Immunosuppressive therapy must be guided by therapeutic drug monitoring (TDM) in paediatric liver (LT) and kidney transplantation (KT) patients to prevent under- and overdosing, which have clinical consequences.

Technical informations